Page last updated: 2024-09-02

cgp 39551 and reserpine

cgp 39551 has been researched along with reserpine in 1 studies

Compound Research Comparison

Studies
(cgp 39551)
Trials
(cgp 39551)
Recent Studies (post-2010)
(cgp 39551)
Studies
(reserpine)
Trials
(reserpine)
Recent Studies (post-2010) (reserpine)
750415,546223436

Protein Interaction Comparison

ProteinTaxonomycgp 39551 (IC50)reserpine (IC50)
Bile salt export pumpHomo sapiens (human)8.7875
ATP-dependent translocase ABCB1Homo sapiens (human)3.2092
Quinolone resistance protein NorAStaphylococcus aureus8.5429
Mu-type opioid receptorHomo sapiens (human)4.152
Chromaffin granule amine transporterHomo sapiens (human)0.05
Synaptic vesicular amine transporterRattus norvegicus (Norway rat)0.0034
Synaptic vesicular amine transporterHomo sapiens (human)0.0147

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maj, J; Rogóz, Z; Skuza, G1

Other Studies

1 other study(ies) available for cgp 39551 and reserpine

ArticleYear
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.
    Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 6, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Biogenic Monoamines; Catalepsy; Central Nervous System Agents; Clonidine; Levodopa; Male; Methyltyrosines; Motor Activity; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reserpine; Tyrosine 3-Monooxygenase

1993